H-CYTE, INC.
201 E Kennedy Blvd., Suite 700
Tampa, FL 33602
July 31, 2020
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, NE
Washington, D.C. 20549
Re: H-CYTE, Inc.
Registration Statement on Form S-1/A
Submitted on July 31, 2020
File No. 333-239629
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, H-CYTE, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:15 p.m., Eastern Standard Time, on August 4, 2020, or as soon thereafter as possible.
| H-CYTE, Inc. | ||
| By: | /s/ Jeremy Daniel | |
| Name: | Jeremy Daniel | |
| Title: | Chief Financial Officer | |
